Literature DB >> 10893363

Cystic fibrosis. End-stage care in Canada.

I Mitchell1, E Nakielna, E Tullis, C Adair.   

Abstract

OBJECTIVES: To determine the circumstances in which individuals with cystic fibrosis (CF) die, the role of different caregivers, and the extent of palliative care for CF patients.
DESIGN: Mailed survey of CF physicians.
SETTING: CF centers in Canada. PATIENTS: All CF deaths in 1996 known to centers in Canada.
RESULTS: The mean age (+/- SD) at death of the 45 individuals included in the study was 25.8 +/- 13.5 years. The major cause of death was respiratory (34 patients; 75.5%). Nutritional concerns were common. Lung transplantation was considered in 42 patients (93.2%), with 7 patients (17.1%) being entered on a list, but it was carried out in only 2 patients (4.4%). Autopsies were performed on only 10 patients (22.2%). Most patients died in hospital (37 patients; 82.2%), and 7 patients (15.6%) died in ICUs while receiving intermittent positive-pressure ventilation. Palliative care was never discussed in 10 patients (25%). In a further 16 patients (40%), it was not discussed until the last month before death.
CONCLUSIONS: Respiratory disease remains the most common cause of death in CF patients. Lung transplantation is frequently considered, but most patients die without having had a transplant. Discussions on end-of-life care could be considered sooner.

Entities:  

Mesh:

Year:  2000        PMID: 10893363     DOI: 10.1378/chest.118.1.80

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Patients with cystic fibrosis should be intubated and ventilated.

Authors:  Ian Ketchell
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

2.  Effects of lung transplantation on inpatient end of life care in cystic fibrosis.

Authors:  Elisabeth P Dellon; Margaret W Leigh; James R Yankaskas; Terry L Noah
Journal:  J Cyst Fibros       Date:  2007-05-03       Impact factor: 5.482

3.  Palliative Care Needs of Individuals with Cystic Fibrosis: Perspectives of Multiple Stakeholders.

Authors:  Elisabeth P Dellon; Melissa Basile; Mara R Hobler; Anna M Georgiopoulos; Elaine Chen; Jessica Goggin; Christopher H Goss; Sarah E Hempstead; Albert Faro; Dio Kavalieratos
Journal:  J Palliat Med       Date:  2020-02-05       Impact factor: 2.947

4.  Caregiver perspectives on discussions about the use of intensive treatments in cystic fibrosis.

Authors:  Elisabeth P Dellon; Mitchell D Shores; Katherine I Nelson; Joanne Wolfe; Terry L Noah; Laura C Hanson
Journal:  J Pain Symptom Manage       Date:  2010-09-09       Impact factor: 3.612

5.  Advance care planning in adults with cystic fibrosis.

Authors:  Gregory S Sawicki; Edward J Dill; Daniel Asher; Deborah E Sellers; Walter M Robinson
Journal:  J Palliat Med       Date:  2008-10       Impact factor: 2.947

6.  An overview of end-of-life issues in the intensive care unit.

Authors:  Thomas J Papadimos; Yasdet Maldonado; Ravi S Tripathi; Deven S Kothari; Andrew L Rosenberg
Journal:  Int J Crit Illn Inj Sci       Date:  2011-07

7.  Improving end-of-life care for adults with cystic fibrosis: an improvement project.

Authors:  Fiona Cathcart; Jayne Wood; Su Madge
Journal:  BMJ Open Qual       Date:  2020-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.